How much of the litigation cost is related to complaints about innovative treatments?
Access to Medical Treatments (Innovation) Bill
Proceeding contribution from
Sarah Wollaston
(Conservative)
in the House of Commons on Friday, 16 October 2015.
It occurred during Debate on bills on Access to Medical Treatments (Innovation) Bill.
About this proceeding contribution
Reference
600 c602Session
2015-16Chamber / Committee
House of Commons chamberLibrarians' tools
Timestamp
2021-11-04 13:31:32 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000382
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000382
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000382